Camille V. Edwards

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

Camille V. Edwards, Nisha Rao, Divaya Bhutani et al. · Blood · 2021 · 96 citations · Full text

One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Camille V. Edwards, Divaya Bhutani, Markus Y. Mapara et al. · Amyloid · 2019 · 37 citations

Alzheimer's Disease, Al Amyloidosis, Immunology +4

Predictors of hematologic response and survival with stem cell transplantation in <scp>AL</scp> amyloidosis: A 25‐year longitudinal study

Joshua Gustine, Andrew Staron, Raphaël Szalat et al. · American Journal of Hematology · 2022 · 35 citations

Cell Therapy, Transplantation, Marrow Transplantation +13

Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma

Camille V. Edwards, Hamza Hassan, Cenk Yildirim et al. · Blood Advances · 2022 · 21 citations · Full text

Immunology, Pathology, Immune System +16

Predictive factors of outcomes in patients with <scp>AL</scp> amyloidosis treated with daratumumab

Raphaël Szalat, Joshua Gustine, J. Mark Sloan et al. · American Journal of Hematology · 2021 · 19 citations · Full text

Rheumatology, Al Amyloidosis, Disease Progression +10